by Truveta Research | Dec 11, 2025 | Research
Respiratory virus–associated hospitalizations increased overall in November 2025 (+91.1%) and now make up 2.5% of all hospitalizations. Respiratory virus–associated hospitalizations increased substantially among children aged 0-4 years old (+73.1%), reaching 3.9% of...
by Truveta Research | Dec 9, 2025 | Featured research, Research, Research Insights
Among women prescribed a semaglutide or tirzepatide medication, the percentage with a PCOS diagnosis increased from 4.6% in 2021 to 5.7% in 2025, a 23.9% relative increase. Nearly all PCOS patients prescribed semaglutide or tirzepatide also had obesity or type 2...
by Truveta staff | Dec 2, 2025 | Research
Extracting meaning from unstructured clinical text remains one of the hardest problems in healthcare. To solve this, many researchers rely on BERT (Bidirectional Encoder Representations from Transformers), a model first developed at Google in 2018. BERT reads language...
by Truveta Research | Nov 25, 2025 | Research
Cannabis-related emergency department (ED) visit rates were significantly higher on Thanksgiving; 25% higher than the Thursday before and 26% higher than the Thursday after the holiday. Rates of cannabis-related ED visits varied by sex and age. Cannabis use has risen...
by Truveta staff | Nov 24, 2025 | Research
In this Truveta Experts analysis, Mantas Dmukauskas, PhD examines first-dose HPV vaccination trends using Truveta’s de-identified electronic health record (EHR) data. The analysis tracks annual age-group patterns and sex differences to clarify how changes in...
by Truveta staff | Nov 18, 2025 | Research
At the Transcatheter Cardiovascular Therapeutics (TCT) conference in October 2025, Johnson & Johnson MedTech presented two large, contemporary analyses that used Truveta Data to compare Impella microaxial heart pumps with intra-aortic balloon pump (IABP) support...
